AUROPHARMA.NSAUROPHARMA.NSNSE
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank43
5Y CAGR-12.3%
Studio
Year-over-Year Change

Year-over-year revenue growth rate

5Y CAGR
-12.3%/yr
Long-term compound
Percentile
P43
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
20259.39%
202416.68%
20235.97%
2022-5.32%
20217.26%
202018.07%
201918.83%
201810.24%
20178.09%
201613.86%